english.prescrire.org > Spotlight > Archives : 2014 > In the March issue of Prescrire International: Tenofovir and chronic hepatitis B

Spotlight: Archives

Every month, the subjects in Prescrire’s Spotlight.

2014 : 1 | 30 | 60

In the March issue of Prescrire International: Tenofovir and chronic hepatitis B

FREE DOWNLOAD In the New Products section of the March issue, Prescrire International examines the new indication for the antiviral drug tenofovir (Viread°) in adolescents. 
Full text available for free download.

Summary

  • Tenofovir is effective in suppressing hepatitis B virus replication.
     
  • However, more data are needed on its harm-benefit balance, especially in adolescents, particularly because of its adverse effects on the kidneys and growing bone.
     
  • Whenever possible, it is best to defer treatment until after the pubertal growth spurt.

Full text available for free download.

 ©Prescrire 1 March 2014

"Tenofovir and chronic hepatitis B" Prescrire Int 2014; 23 (147): 65. (Pdf, free)

Download the full review
Pdf, free